Publication:
Thymic Neuroendocrine Carcinoma Presenting as Cushing's Syndrome: Treatment with Octreotide Combined with Surgery and Radiotherapy

dc.contributor.authorVELİOĞLU, ARZU
dc.contributor.authorYILDIZELİ, BEDRETTİN
dc.contributor.authorYAVUZ, DİLEK
dc.contributor.authorAŞICIOĞLU, EBRU
dc.contributor.authorYÜKSEL, MUSTAFA
dc.contributor.authorsAsicioglu, Ebru; Gonenli, Gokhan; Kahveci, Arzu; Yildizeli, Bedrettin; Deyneli, Oguzhan; Yavuz, Dilek; Yuksel, Mustafa; Akalin, Sema
dc.date.accessioned2022-03-12T17:51:03Z
dc.date.accessioned2026-01-10T17:12:43Z
dc.date.available2022-03-12T17:51:03Z
dc.date.issued2011
dc.identifier.doi10.1159/000323348
dc.identifier.eissn1423-0240
dc.identifier.issn0378-584X
dc.identifier.pubmed21346385
dc.identifier.urihttps://hdl.handle.net/11424/230248
dc.identifier.wosWOS:000287665800009
dc.language.isoeng
dc.publisherKARGER
dc.relation.ispartofONKOLOGIE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCushing's syndrome
dc.subjectThymic neuroendocrine carcinoma
dc.subjectCarcinoids
dc.subjectOctreotide
dc.subjectRECEPTOR SUBTYPES
dc.subjectFOLLOW-UP
dc.subjectTUMORS
dc.subjectSCINTIGRAPHY
dc.subjectNEOPLASM
dc.subjectTHERAPY
dc.subjectACTH
dc.titleThymic Neuroendocrine Carcinoma Presenting as Cushing's Syndrome: Treatment with Octreotide Combined with Surgery and Radiotherapy
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage49
oaire.citation.issue1-2
oaire.citation.startPage46
oaire.citation.titleONKOLOGIE
oaire.citation.volume34

Files